Thrombosis in coronary drug-eluting stents: Report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006

Circulation

Volumn 115, Issue 17, 2007, Pages 2352-2357

  Laskey, Warren K ^a   Yancy, Clyde W ^b   Maisel, William H ^c,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Restenosis; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DEVICE; DRUG ELUTING STENT; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HEART INFARCTION; HUMAN; MORTALITY; PATIENT EDUCATION; PRIORITY JOURNAL; RESTENOSIS; SAFETY; THROMBOSIS;

CLINICAL TRIALS; CORONARY DISEASE; DEVICE APPROVAL; DRUG DELIVERY SYSTEMS; HUMANS; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS;

EID: 34247644924     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.688416     Document Type: Conference Paper

References (0)